Quick Answer
MIMEDX GROUP, INC. reported R&D Expense of $15.10 million for fiscal year 2025.
MIMEDX GROUP, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $15.10M | +22.3% |
| 2024 | $12.34M | -2.6% |
| 2023 | $12.66M | -0.3% |
| 2022 | $12.70M | +27.9% |
| 2021 | $9.93M | -15.2% |
| 2020 | $11.71M | +5.2% |
| 2019 | $11.14M | -29.3% |
| 2018 | $15.77M | -11.9% |
| 2017 | $17.90M | +24.8% |
| 2016 | $14.34M | +70.5% |
| 2015 | $8.41M | +19.3% |
| 2014 | $7.05M | +45.6% |
| 2013 | $4.84M | +67.9% |
| 2012 | $2.88M | -3.1% |
| 2011 | $2.98M | +8.1% |
| 2010 | $2.75M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.70M | +26.9% | +12.1% |
| June 30, 2025 | $3.30M | +9.7% | -0.8% |
| March 31, 2025 | $3.33M | +17.1% | +14.1% |
| September 30, 2024 | $2.92M | -5.1% | -3.1% |
| June 30, 2024 | $3.01M | -18.0% | +6.0% |
| March 31, 2024 | $2.84M | -18.5% | -7.6% |
| September 30, 2023 | $3.08M | -48.3% | -16.3% |
| June 30, 2023 | $3.67M | -33.4% | +5.4% |
- MIMEDX GROUP, INC. showed an increase of +22.3% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, MIMEDX GROUP, INC.’s r&d expense has grown by 448.3% (from $2.75 million to $15.10 million).
- The most recent figure is from MIMEDX GROUP, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: